AzTrials
AzTrials

Rotator Cuff TearLiTransNCT04819724

Load-induced Changes in Glenohumeral Translation in Patients With Rotator Cuff Tear

A study testing 3D motion analysis, isometric shoulder strength by dynamometer and fluoroscopic images of each shoulder in people with Rotator Cuff Tear, run by University Hospital, Basel, Switzerland at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study is to investigate the dose-response relationship between load-induced muscle activation (liMA) and load-induced glenohumeral translation (liTr) in patients with rotator cuff tears and asymptomatic control subjects. Read more about this study

Who is it for?
Ages 20 to 85 yearsHealthy volunteers can take part
Conditions the study is for
Rotator Cuff Tear
What is being tested?
3D motion analysis, isometric shoulder strength by dynamometer and fluoroscopic images of each shoulder
Could I receive a placebo?
No, everyone receives an active treatment
How many people
75 participants
Where
1 siteSwitzerland
Study dates
4 May 2021to 31 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 85 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Diagnosed unilateral rotator cuff tear
  • Partial or complete supraspinatus muscle tear
  • With or without injury to other rotator cuff muscles
  • No previous known elbow and shoulder injury or symptoms

Who cannot join

  • Prior operative treatment of the ipsilateral shoulder or elbow
  • Clinical history or symptoms of the contralateral glenohumeral joint
  • Range of motion <30° in abduction and flexion
  • Clinical history of the glenohumeral joint
  • Prior conservative or operative treatment of the shoulder or elbow
  • Range of motion <90° in abduction and flexion
Show all 17Show fewer
  • General exclusion criteria:
  • Inability to provide informed consent
  • Body mass index (BMI) > 35 kg/m2 (Excessive skin movement)
  • Neuromuscular disorders affecting upper limb movement
  • Additional pathologies that influence the mobility of the shoulder joints
  • Contraindications for MRI (e.g. neurostimulator and claustrophobia)
  • Prior neuromuscular impairment (e.g. stroke)
  • Diagnosed active rheumatic disorder
  • Other major medical problems
  • Pregnancy
  • Patients currently enrolled in another experimental (interventional) protocol

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Department of Orthopaedics and Traumatology, University Hospital Basel

    Basel, 4031

Other trials in Switzerland

About this study

Official title: LiTrans - Influence of Additional Weight Carrying on Load-induced Changes in Glenohumeral Translation in Patients With Rotator Cuff Tear - a Translational Approach

The study is to investigate the dose-response relationship between load-induced muscle activation (liMA) and load-induced glenohumeral translation (liTr) in patients with rotator cuff tears and asymptomatic control subjects.

Furthermore the study is to investigate the in vivo dose-response relationship between additional weight and glenohumeral translation, to understand the biological variation in liTr, the influence of disease pathology on the liTr, the potential compensation by muscle activation and muscle size, and the influence of liTr on patient outcomes.

Read the detailed description

This project is to test the overall hypothesis that rotator cuff tear affects glenohumeral translation and that this functional instability depends on additional load applied, on anatomical and morphological variations, and on type and severity of the injury. The study is to investigate the dose-response relationship between load-induced muscle activation (liMA) and load-induced glenohumeral translation (liTr) in patients with rotator cuff tears and asymptomatic control subjects.

Furthermore the study is to investigate the in vivo dose-response relationship between additional weight and glenohumeral translation, to understand the biological variation in liTr, the influence of disease pathology on the liTr, the potential compensation by muscle activation and muscle size, and the influence of liTr on patient outcomes.

This study entails cross-sectional experimental multimodal (clinical, biomechanical, radiological) data collection with multiple conditions and a control group.

Being tested
3D motion analysis, isometric shoulder strength by dynamometer, fluoroscopic images of each shoulder, Bilateral shoulder Magnetic Resonance Imaging (MRI), data collection by health questionnaires
Keywords
glenohumeral translation, Load-induced Glenohumeral Translation (liTr ), Load-induced Muscle Activation (liMA)
Medical subject headings
Rotator Cuff Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 3D motion analysisDiagnostic test

    30° arm abduction in the scapular plane will be performed with and without a handheld weight of 1, 2, 3, and 4 kg. All movements will be done bilaterally. Electromyographic (EMG) data of arm and trunk muscles will be recorded using surface electrodes. Participants will be asked to perform full arm abduction with different rotations (internal, neutral and external rotation), flexion and internal-/external rotations movements (without additional handheld weight).

  • isometric shoulder strength by dynamometerDiagnostic test

    isometric shoulder strength for abduction and internal/external rotation will be assessed with a isometric shoulder strength for abduction and internal/external rotation will be assessed with a dynamometer

  • fluoroscopic images of each shoulderDiagnostic test

    fluoroscopic images (Multitom Rax, Siemens Healthineers, Erlangen, Germany) of each shoulder will be taken during the 30° arm abduction test with and without a handheld weight (0, 2, and 4kg)

  • Bilateral shoulder Magnetic Resonance Imaging (MRI)Diagnostic test

    MRI of both shoulders will be taken

  • data collection by health questionnairesOther

    data collection by health questionnaires

Study groups in NCT04819724
Study groupRoleWhat they receive
Group 1: patient group (unilateral rotator cuff tear)OtherGroup 1: 25 patients with unilateral symptomatic rotator cuff tear
Receives: Diagnostic Test: 3D motion analysis; Diagnostic Test: isometric shoulder strength by dynamometer; Diagnostic Test: fluoroscopic images of each shoulder; Diagnostic Test: Bilateral shoulder Magnetic Resonance Imaging (MRI); Other: data collection by health questionnaires
Group 2: control group (asymptomatic volunteers)OtherGroup 2: (asymptomatic volunteers) 25 asymptomatic control subjects (age and sex distribution matching the patient group)
Receives: Diagnostic Test: 3D motion analysis; Diagnostic Test: isometric shoulder strength by dynamometer; Diagnostic Test: fluoroscopic images of each shoulder; Diagnostic Test: Bilateral shoulder Magnetic Resonance Imaging (MRI); Other: data collection by health questionnaires
Group 2: young control group (young asymptomatic volunteers)OtherGroup 3: (young asymptomatic volunteers) 25 asymptomatic control subjects, 20 to 30 years (sex distribution matching the patient group)
Receives: Diagnostic Test: 3D motion analysis; Diagnostic Test: isometric shoulder strength by dynamometer; Diagnostic Test: fluoroscopic images of each shoulder; Diagnostic Test: Bilateral shoulder Magnetic Resonance Imaging (MRI); Other: data collection by health questionnaires

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Disabilities of arm, shoulder and hand (Quick DASH) questionnaire

    30-item questionnaire that looks at the ability of a patient to perform certain upper extremity activities. This questionnaire is a self-report questionnaire that patients can rate difficulty and interference with daily life on a 5 point Likert scale (1 being no difficulty, 5 being unable).

    Measured: at baseline (approximate duration for all questionnaires: 20 minutes)

  2. Constant Score

    The Constant-Murley score (CMS) is a 100-points scale composed of a number of individual parameters. These parameters define the level of pain and the ability to carry out the normal daily activities of the patient. The test is divided into four subscales: pain (15 points), activities of daily living (20 points), strength (25 points) and range of motion: forward elevation, external rotation, abduction and internal rotation of the shoulder (40 points). The higher the score, the higher the quality of the function.

    Measured: at baseline (approximate duration for all questionnaires: 20 minutes)

  3. American Shoulder and Elbow Surgeons (ASES) Shoulder Score

    The American Shoulder and Elbow Surgeons Shoulder Score (ASES) is a mixed outcome reporting measure, applicable for use in all patients with shoulder pathology regardless of their specific diagnosis. The ASES questionnaire is composed of both a physician-rated component and a patient-reported component. The patient questions focus on joint pain, instability, and activities of daily living. The pain and functional portions are summed to obtain the final ASES score with higher scores indicating better outcomes.

    Measured: at baseline (approximate duration for all questionnaires: 20 minutes)

  4. Subjective Shoulder Value (SSV)

    The SSV is defined as a patient's subjective shoulder assessment expressed as a percentage of an entirely normal shoulder, which would score 100%.

    Measured: at baseline (approximate duration for all questionnaires: 20 minutes)

  5. numerical pain rating scale (NRS) score

    The Numeric Pain Rating Scale (NPRS) is a unidimensional measure of pain intensity in adults (from 0-10: "0" = no pain. "10" = the most intense pain imaginable)

    Measured: at baseline (approximate duration for all questionnaires: 20 minutes)

  6. Loaded shoulder abduction test with motion analysis

    The subject will lift their arm to 30° shoulder abduction in the scapular plane, data will be captured holding 0, 1, 2, 3, and 4 kg, respectively, in their hand. Reflective surface markers will be placed bilaterally on the participants' trunk and arms. Position of these markers will be recorded using infrared cameras that only record the reflections of the markers. Additionally, inertial sensors will be positioned on the subjects' thorax, scapulae, humeri and forearms.

    Measured: at baseline (approximate duration for motion analysis: 50 minutes)

  7. Loaded shoulder abduction test with single plane fluoroscopic images

    fluoroscopic images (Multitom Rax, Siemens Healthineers, Erlangen, Germany) of each shoulder will be taken during the 30° arm abduction test with and without a handheld weight (0, 2, and 4kg)

    Measured: at baseline (approximate duration for motion analysis: 50 minutes).

  8. Load-induced muscle activity from electromyography (EMG)

    During arm movements in the loaded shoulder test and muscle strength tests, muscle activation of the infraspinatus, biceps brachii, anterior, middle and posterior part of the deltoid, clavicular part of the pectoralis major, latissimus dorsi and the upper part of the trapezius will be measured bilaterally using a 16-channel EMG system

    Measured: at baseline (approximate duration for motion analysis: 50 minutes)

  9. Glenohumeral translation from single plane fluoroscopy

    the vertical distance of the glenohumeral joint centre (GHJC) and the radiopaque acromion marker will be measured. Fluoroscopy (FL) based liTr will be calculated for each participant as the slope of the regression of the negative GHJC to acromion distance measurements on the load magnitude.

    Measured: at baseline (approximate duration for motion analysis: 50 minutes)

  10. Glenohumeral translation from instrumented motion analysis

    The vertical distance of the GHJC to the acromion marker will be calculated for a neutral trial and with the arm in 30° shoulder abduction for each loading condition. Motion analysis (MA) based liTr will be calculated for each participant as the slope of the regression of the negative GHJC to acromion distance measurements on the load magnitude

    Measured: at baseline (approximate duration for motion analysis: 50 minutes)

  11. Critical shoulder angle (CSA)

    Subject's CSA will be measured on an anterior-posterior double-obliquity fluoroscopy image of the shoulder as the angle subtended by a line parallel to the glenoid and a line through the inferior-lateral edge of the glenoid and the inferior-lateral edge of the acromion. The CSA is reproducible and significantly greater in patients with rotator cuff tears than the general population. High angles (>35°-38°) have been associated with rotator cuff tears and greater joint instability.

    Measured: at baseline (approximate duration for motion analysis: 50 minutes)

  12. Glenoid inclination (GI)

    GI will be measured on the fluoroscopy image as the angle between a line from the upper to the lower glenoid rim (glenoid plane) and a second line set on the floor of the supraspinous fossa. Abnormal GI might be associated with rotator cuff tears and superior humeral head migration.

    Measured: at baseline (approximate duration for motion analysis: 50 minutes)

  13. Greater tuberosity angle (GTA)

    GTA will be measured as the angle between a line parallel to the humerus diaphysis through the GHJC and a line from the upper border of the humeral head to the most superolateral edge of the greater tuberosity. A GTA of more than 70° has been observed to predict rotator cuff tear.

    Measured: at baseline (approximate duration for motion analysis: 50 minutes)

  14. Muscle cross sectional area (MCSA)

    The MCSA of all rotator cuff muscles will be measured at two different positions on parasagittal reformatted images. MCSA of the deltoid will also be measured on the axial plane at the middle of the glenoid.

    Measured: at baseline (approximate duration is approximately 1 hour and 15 minutes)

  15. Tear size retrieved from MR images

    Tear size will be classified into partial (1) or complete supraspinatus muscle tear (2).

    Measured: at baseline (approximate duration is approximately 1 hour and 15 minutes)

  16. Tear type retrieved from MR images

    Tear type will be classified into supraspinatus tear without injury to other rotator cuff muscles (type A) and with injury to other rotator cuff muscles (type B). Both will be used as indicators for injury severity

    Measured: at baseline (approximate duration is approximately 1 hour and 15 minutes)

  17. Isometric shoulder muscle strength for abduction and internal/external rotation

    Shoulder muscle strength will be tested under isometric conditions using a dynamometer. The maximum of 3 trials will be calculated and recorded as the participant's maximum isometric strength.

    Measured: at baseline (approximate duration: 40 minutes).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Mar 2021
  2. Study start4 May 2021
  3. Primary completion31 Dec 2022
  4. Study completion31 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
cross-sectional experimental multimodal (clinical, biomechanical, radiological) data collection with multiple conditions and a control group
Masking
None (open label)
Enrolment
75 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04819724
Sponsor's protocol ID
2021-00182; mu21Muendermann
Acronym
LiTrans
Status last verified
Apr 2024
First submitted
24 Mar 2021
Last updated
12 Apr 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Croci E, Hess H, Genter J, Baum C, Kovacs BK, Nuesch C, Baumgartner D, Gerber K, Muller AM, Mundermann A. Severity of rotator cuff disorders and additional load affect fluoroscopy-based shoulder kinematics during arm abduction. J Orthop Traumatol. 2024 Jun 8;25(1):30. doi: 10.1186/s10195-024-00774-2.

    PubMed 38850466
  • Croci E, Warmuth F, Baum C, Kovacs BK, Nuesch C, Baumgartner D, Muller AM, Mundermann A. Load-induced increase in muscle activity during 30 degrees abduction in patients with rotator cuff tears and control subjects. J Orthop Traumatol. 2023 Aug 4;24(1):41. doi: 10.1186/s10195-023-00720-8.

    PubMed 37542140
  • Croci E, Eckers F, Nuesch C, Aghlmandi S, Kovacs BK, Genter J, Baumgartner D, Muller AM, Mundermann A. Load-Induced Glenohumeral Translation After Rotator Cuff Tears: Protocol for an In Vivo Study. JMIR Res Protoc. 2022 Dec 23;11(12):e43769. doi: 10.2196/43769.

    PubMed 36563028

Questions about this trial

What is this clinical trial studying?

A study testing 3D motion analysis, isometric shoulder strength by dynamometer and fluoroscopic images of each shoulder in people with Rotator Cuff Tear, run by University Hospital, Basel, Switzerland at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 17 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Disabilities of arm, shoulder and hand (Quick DASH) questionnaire (time frame: at baseline (approximate duration for all questionnaires: 20 minutes)). The study lists 17 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04819724, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in